San Diego-based BioAtla, a company that produces cancer therapies, wrapped its initial public offering.
How to buy Bioatla Inc stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – BCAB. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Bioatla Inc stock price (NASDAQ: BCAB)
Use our graph to track the performance of BCAB stocks over time.Bioatla Inc shares at a glance
Latest market close | $3.68 |
---|---|
52-week range | $2.01 - $12.15 |
50-day moving average | $7.90 |
200-day moving average | $5.97 |
Wall St. target price | $26.14 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-2.85 |
Buy Bioatla Inc stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Bioatla Inc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Bioatla Inc price performance over time
Historical closes compared with the close of $3.68 from 2023-01-26
1 week (2023-01-20) | 5.75% |
---|---|
1 month (2022-12-27) | -52.82% |
3 months (2022-10-27) | -44.33% |
6 months (2022-07-27) | -0.81% |
1 year (2022-01-27) | -58.32% |
---|---|
2 years (2021-01-27) | -91.63% |
3 years (2020-01-23) | N/A |
5 years (2018-01-23) | N/A |
Bioatla Inc financials
Gross profit TTM | $-58,024,000 |
---|---|
Return on assets TTM | -27.61% |
Return on equity TTM | -54.83% |
Profit margin | 0% |
Book value | $3.80 |
Market capitalisation | $182.7 million |
TTM: trailing 12 months
Bioatla Inc share dividends
We're not expecting Bioatla Inc to pay a dividend over the next 12 months.
Bioatla Inc share price volatility
Over the last 12 months, Bioatla Inc's shares have ranged in value from as little as $2.01 up to $12.15. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bioatla Inc's is 0.633. This would suggest that Bioatla Inc's shares are less volatile than average (for this exchange).
To put Bioatla Inc's beta into context you can compare it against those of similar companies.
- XBiotech (XBIT.US): 1.0886
- Genmab AS (GMAB.US): 0.7533
- Mersana Therapeutics (MRSN.US): 1.7175
Bioatla Inc overview
BioAtla, Inc. , a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, melanoma, and ovarian cancer; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. BioAtla, Inc. was founded in 2007 and is based in San Diego, California. .
Bioatla Inc in the news
Recent uptick might appease BioAtla, Inc. (NASDAQ:BCAB) institutional owners after losing 56% over the past year
BioAtla Provides Clinical Program Updates and Upcoming 2023 Milestones
BioAtla Provides Clinical Program Updates and Upcoming 2023 Milestones
Frequently asked questions
What percentage of Bioatla Inc is owned by insiders or institutions?Currently 12.858% of Bioatla Inc shares are held by insiders and 60.032% by institutions. How many people work for Bioatla Inc?
Latest data suggests 56 work at Bioatla Inc. When does the fiscal year end for Bioatla Inc?
Bioatla Inc's fiscal year ends in December. Where is Bioatla Inc based?
Bioatla Inc's address is: 11085 Torreyana Road, San Diego, CA, United States, 92121 What is Bioatla Inc's ISIN number?
Bioatla Inc's international securities identification number is: US09077B1044
More guides on Finder
-
How to buy TXO Energy (TXO) stock when it goes public
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock when it goes public
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert